• No notifications yet.
  • Sign Out
logo image
  • logo image
Registered User? Login
Forgot Password?
Sign Up
loader image
New User? Sign Up
Forgot Password?
Login
loader image

    Targeted Oncology™ & Oncology Nursing News® Community Case Forum™

    Monday July 21, 2025 | 5:45 - 8:30 PM CT

    Hutton Hotel | Nashville, TN 

    CONNECT WITH THE COMMUNITY

    The Community Case Forum is a special opportunity to gather IN-PERSON only.


    No virtual options are available.

    After arriving at registration check-in, you'll spend some time networking with peers while enjoying small plate refreshments and cocktails. Case-based discussions will follow the networking reception and the evening will adjourn by 8:30 PM. 


    Eligibility
    Participants must be medical oncologists, hematologists, or advanced practice providers currently treating patients in a community practice setting. With prior approval from our registration team, a small number fellows may be eligible to attend.


    Discussion Topics

    You choose the topic that is best aligned for the patients you're seeing in your practice now. Our moderators will present case-based clinical profiles to generate discussion among participants around recent clinical data and potential treatment strategies.


    Discussion Topics Include:


    Immunotherapy for Locally Advanced Skin Cancer

    During this conversation, we will explore two clinical cases that cover CSCC and Basal Cell Cancer treatment decision making.

    Moderated by: Kent Shih, MD (Tennessee Oncology) 

    Key contributor: Brent Moody, MD, FAAD, FACP (Heritage Medical Associates)

    This discussion is only open to medical oncologists/hematologists.



    The Evolving Second-Line Treatment Landscape in ER+/HER2- Metastatic Breast Cancer*CLOSED: AT CAPACITY*

    In this discussion, we will discuss two cases surrounding the treatment of ER+, HER2-negative metastatic breast cancer, highlighting the significance of ESR1 mutations, along with associated testing and treatment strategies with targeted therapies and ADC-based approaches.

    Moderated by: Melissa Rikal, FNP-BC, AOCNP

    This discussion is only open to advanced practice providers.




    Moderators

    image placeholder
    BM
    Dr. Brent Moody, MD, FAAD, FACP
    Heritage Medical Associates
    image placeholder
    KS
    Dr. Kent Shih, MD
    Medical Oncologist
    Tennessee Oncology
    image placeholder
    MR
    Melissa Rikal, FNP-BC, AOCNP
    Sarah Cannon Research Institute

    WHEN
    Monday July 21, 2025

    5:45 PM - 6:30 PM CT
    Registration Check-In 
    6:00 PM - 8:30 PM CT
    Networking Reception & Discussions
    WHERE

    Hutton Hotel

    1808 West End Ave Nashville, TN 37203

    MARKET RESEARCH PARTICIPATION

    Healthcare Research & Analytics offers compensation of  $750 to oncologists/hematologists and $500 to advanced practice providers and fellows  for their consultative insights during the forum's discussions, responses to polling questions and completion of a postevent survey.


    Your feedback provides HRA® with a pulse on physicians’ educational needs in a regional event.


    Participants must be medical oncologists, hematologists, or advanced practice providers currently treating patients in a community practice setting. With prior approval from our registration team, a small number fellows may be eligible to attend. 


    Seating is limited, and registration will close when capacity is reached.  

    Reserve your seat today for the Targeted Oncology & Oncology Nursing News Community Case Forum.


    Presented in Partnership With:

    Targeted Healthcare Communications® — an MJH Life Sciences® Brand

    Copyright 2025 © Intellisphere, LLC.  All Rights Reserved.

    Terms & Conditions

    Privacy Policy

     

    Do Not Sell My Info
Looking for your ticket? Contact the organizer
Looking for your ticket? Contact the organizer